ABVC BioPharma, Inc.'s total assets for Q3 2024 were $14.46M, a decrease of -1.17% from the previous quarter. ABVC total liabilities were $6.48M for the fiscal quarter, a -4.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.